V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Omega Therapeutics (OMGA) Financial results for the second quarter of 2021.

10.09.2021

GAAP net loss is -$3,36.

As of June 30, 2021 cash and cash equivalents are $122.4 million which does not include gross IPO income to the value of $141.1 million.